LJPC Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into LJPC


Also see:
LJPC stock yearly return 2012
LJPC stock yearly return 2013
LJPC stock yearly return 2014
LJPC stock yearly return 2015
LJPC stock yearly return 2016
LJPC stock yearly return 2017
LJPC stock yearly return 2018
LJPC stock yearly return 2019
LJPC stock yearly return 2020
LJPC stock yearly return 2021
LJPC YTD return
Compare LJPC average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 08/23/2012
End date: 08/22/2022
Start price/share: $0.05
End price/share: $6.22
Dividends collected/share: $0.00
Total return: 12,340.00%
LJPC Average Annual Return: 61.97%
Starting investment: $10,000.00
Ending investment: $1,244,284.28
Years: 10.00


LJPC average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
La Jolla Pharmaceutical is focused on the commercialization of therapies. GIAPREZA™ (angiotensin II) injection is a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. XERAVA™ (eravacycline) for injection is a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections. Co. owns various product candidates that are in preclinical development including: TP-6076, an IV formulation of a synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The LJPC average annual return 10 years is shown above.

The Average Annual Return on the LJPC average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether LJPC average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the LJPC average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree LJPC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
La Jolla Pharmaceutical (LJPC) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

LLY Average Annual Return
LMAT Average Annual Return
LNSR Average Annual Return
LNTH Average Annual Return
LOGC Average Annual Return
LPCN Average Annual Return
LPTX Average Annual Return
LQDA Average Annual Return
LRMR Average Annual Return
LTRN Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, La Jolla Pharmaceutical (LJPC) ranks in the top 25% of all stocks whose returns we have reviewed.
What has the average annual return been for LJPC over the past ten years?
✔️Accepted answer: The ten year LJPC average annual return has been 61.97%.

What start date was used in your LJPC average annual return calculation?
✔️Accepted answer: The start date was 08/23/2012.

What end date was used in your LJPC average annual return calculation?
✔️Accepted answer: The end date was 08/22/2022.

If I had invested $10,000 into LJPC ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 08/22/2022, you would have $1,244,284.28.

What does that work out to on a total return basis?
✔️Accepted answer: The LJPC ten year total return ending 08/22/2022 works out to 12,340.00%.


Also see:
LJPC stock yearly return 2012
LJPC stock yearly return 2013
LJPC stock yearly return 2014
LJPC stock yearly return 2015
LJPC stock yearly return 2016
LJPC stock yearly return 2017
LJPC stock yearly return 2018
LJPC stock yearly return 2019
LJPC stock yearly return 2020
LJPC stock yearly return 2021
LJPC YTD return
 

LJPC Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2022, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.